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Adverse reactions to alcoholic beverages are frequent and 
could be related to differences in metabolism between different 
ethnic groups. Asian people, for instance, have impaired 
alcohol metabolism and experience flushing (oriental flushing 
syndrome) after ingesting alcoholic beverages [1]. Linneberg et 
al [2] showed that Caucasians from Denmark with genetically 
determined fast metabolism of ethanol had an increased risk 
of alcohol-induced hypersensitivity reactions—much in the 
same way as Asian people—albeit because of different genes. 
Adverse reactions to the alcoholic beverage may also be due 
to foods [3] and food additives, such as preservatives [4]. 
Several authors have reported adverse reactions to alcohol 
and its metabolites (acetaldehyde [5,6] and acetic acid [7,8]).
We present the case of a 25-year-old woman with a 
personal history of atopy (allergic rhinitis) who complained of 
generalized urticaria and nausea immediately after ingestion of 
different alcoholic beverages (Port wine, white wine, vermouth, 
and beer), even in small amounts. The patient had been having 
these reactions for about 18 months. She had not experienced 
reactions to soft drinks (eg, nonalcoholic beer), vinegar, or 
foods, including foods cooked with alcoholic beverages. The 
episodes only occurred after ingestion of alcohol. She was 
referred to our immunoallergology outpatient clinic for an 
extensive diagnostic workup comprising a complete blood 
count, biochemistry, determination of serum immunoglobulins, 
skin prick tests with aeroallergens, and prick-prick tests with the 
suspect alcoholic beverages (Port wine, white wine, vermouth, 
and beer). The results of the blood tests were all normal, and 
those of the prick tests with aeroallergens were positive to 
grass pollen (4 mm) and Dermatophagoides pteronyssinus 
(4 mm) (Merck-Serono). Prick-prick tests with alcoholic 
beverages were negative. We then performed a single-blind 
oral challenge test with ethanol absolute (96°) diluted in 
orange juice (Compal Fresh), starting with a dose of 200 mL of 
orange juice alone (placebo), which was latter combined with 
5 mL of ethanol. Twenty minutes after this dose, the patient 
reported palmar pruritus with no other symptoms. Therefore, 
we administered another dose of orange juice and 5 mL of 
ethanol. About 15 minutes later she complained of palmar 
and plantar pruritus, which was accompanied by erythema and 
urticaria on the anterior surface of the left arm. Oral cetirizine 
was administered, and her condition resolved completely after 
1 hour. We subsequently performed prick-prick tests with 
ethanol absolute (at concentrations of 10% and 96%), acetic 
acid (at 0.6%, 1.2%, and 9.6%), and acetaldehyde (at 0.1%, 
1%, and 10%) [9]. The results were positive for acetic acid 
at 1.2% and 9.6%, with mean wheal diameters of 3 mm and 
5 mm, respectively. We also performed prick-prick tests with 
acetic acid at 3 concentrations in a control group of atopic and 
nonatopic patients (3 each). The results were negative. Finally, 
the patient underwent a placebo-controlled, single-blind oral 
challenge test with increasing doses of sodium metabisulfite 
(Bial-Aristegui, 10 mg up to a cumulative dose of 100 mg). 
The results were negative. 
We report the case of a patient who experienced urticaria 
immediately after ingestion of various alcoholic beverages 
(even in small amounts). The clinical history suggests that 
alcohol is the culprit agent, since the patient tolerated all other 
foods and had never experienced a reaction to food not ingested 
simultaneously with alcoholic beverages. Furthermore, the 
patient tolerated meals cooked with alcoholic beverages; 
consequently, it seems that alcohol was responsible for the 
reaction, since alcohol evaporates when cooked. The patient 
also tolerated processed foods that are traditionally high in 
additives such as sulfites. Therefore, we started the workup 
by performing skin prick tests with the drinks involved (Port 
wine, white wine, vermouth, and beer), and the results were 
negative. We then performed an oral challenge test with 
alcohol, which seemed to be the causative agent. We used a 
previously described protocol [9], with orange juice both as 
placebo and as a vehicle for the intake of alcohol, which was 
administered at increasing doses (5, 10, and 15 mL; 30 minutes 
between each dose). We chose to repeat the first dose of alcohol 
instead of increasing it, because the patient experienced palmar 
pruritus after intake of 5 mL. Unlike Ehlers et al [1], who did 
not record positive results until a cumulative dose of 30 mL was 
reached, we observed a reaction after a cumulative dose of only 
10 mL. Furthermore, the reaction was similar to that initially 
reported by the patient (Figure). Alcohol is metabolized within 
minutes after ingestion in acetaldehyde and acetic acid [10]. 
Therefore, after establishing alcohol as the culprit agent, we 
continued to study whether these metabolites were implicated 
by performing skin prick tests to acetic acid at nonirritant 
concentrations [9]. The results were positive for the patient 
but negative in the controls. Finally, the oral challenge test 
with sulfites was negative, thus ruling out involvement of the 
most commonly implicated additives in adverse reactions to 
alcoholic beverages. Keller and Schwanitz [5] suggested that 
a positive reaction with a small amount of alcohol, together 
with a positive skin prick test result to acetic acid, supports the 
hypothesis that the metabolite is responsible for symptoms. 
However, the authors did not consider this mechanism to 
be a type I hypersensitivity reaction and preferred the term 
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anaphylactoid reaction. On the other hand, Boehncke and 
Gall [9] showed that in patients for whom alcohol itself was the 
culprit agent, reactions were observed at a higher cumulative 
dose of alcohol (>30 mL) in the oral challenge test, whereas 
all skin test results were negative. 
7. Sticherling M, Brasch J, Brüning H, Christophers E. Urticarial 
and anaphylactoid reactions following ethanol intake. Br J 
Dermatol. 1995 Mar;132(3):464-7.
8. Kelso JM, Keating MU, Squillace DL, O'Connell EJ, Yunginger 
JW, Sachs MI. Anaphylactoid reaction to ethanol. Ann Allergy. 
1990;64(5):452-4.
9. Boehncke WH, Gall H. Ethanol metabolite acetic acid as 
causative agent for type-1 hypersensitivity-like reactions to 
alcoholic beverages. Clin Exp Allergy. 1996;26(9):1089-91.
10. Baraona E, Julkunen R, Tannenbaum L, Lieber CS. Role of 
intestinal bacterial overgrowth in ethanol production and 
metabolism in rats. Gastroenterology. 1986;90(1):103-10.
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Figure. Patient’s reaction to ethanol oral challenge test. A, Urticarial 
lesions on the arm; B, Palmar erythema.
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We report the case of a patient with immediate-type 
reaction to alcohol. Given the patient's history and the results 
of the diagnostic workup, we think that the causal agent is 
acetic acid. The reaction appears to be IgE-mediated.
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Pitahaya, also known as dragon fruit, belongs to the 
Cactaceae family. There are 2 varieties: red pitahaya, which 
is from Central America, and yellow pitahaya (Selenicereus 
megalanthus), which is from Asia. Yellow pitahaya has a 
grayish-white flesh, with numerous edible black seeds and 
yellow skin. It is generally consumed fresh and is used to 
prepare soft drinks, juices, jelly, ice cream, and yoghurt. We 
report the case of a patient who was referred to our department 
because of an allergic reaction after eating fresh yellow 
pitahaya on 2 occasions. 
The patient was a 7-year-old girl who complained 
of intense pruritus on her neck and back after eating 
yellow pitahaya. The pruritus resolved several hours after 
administration of oral dexchlorpheniramine at home. One 
week later, 5 minutes after eating yellow pitahaya, she 
presented generalized pruritus, facial erythema, and urticaria, 
which resolved after administration of antihistamines and 
corticosteroids in the emergency department. The patient 
tolerated other fruits, nuts, and vegetables and had no 
reactions to latex. The only remarkable feature of her clinical 
history was mild new-onset rhinitis in spring for which she 
had not received treatment.
Skin prick tests were performed with profilin, latex (ALK-
Abelló), fruit, nuts (Leti), commercial extracts of the most 
common pollens in our catchment area, and commercial peach 
extract containing lipid transfer protein (LTP) (30 µg/mL, 
ALK-Abelló). The only positive result was for Gramineae. 
A prick-to-prick test with yellow pitahaya was negative for 
both skin and flesh. Total IgE was 16 kU/L. Ten minutes 
after an oral challenge with yellow pitahaya (half a fruit), 
the patient developed pruritic wheals on her back, abdomen, 
and arms. The symptoms resolved with intramuscular 
methylprednisolone and dexchlorpheniramine.
In order to study the yellow pitahaya allergens recognized 
in our patient, we first obtained pitahaya extract, which was 
lyophilized and triturated before being extracted (10%) in 
0.9% saline solution with magnetic stirring for 90 minutes at 
4ºC. The solution was centrifuged and the supernatant filtered 
(0.4 µm) before storage in aliquots at –20ºC until use. 
Both the pitahaya extract and the molecular weight 
markers were analyzed using SDS-PAGE (16% acrylamide 
gel) under nonreducing conditions using the method described 
by Laemmli [1]. The polyacrylamide gel proteins were 
transferred electrophoretically onto nitrocellulose strips [2]. 
Once the transfer was complete, the strips were saturated with 
1% casein in phosphate-buffered saline (PBS) for 1 hour at 
room temperature before being incubated for 18 hours with 
the patient’s serum (diluted 1:5). As a negative control, 1 strip 
containing the same extract was incubated with 1% casein in 
PBS. After washing with 0.1% Tween-20 in PBS, the strips 
were incubated for 2 hours at room temperature with anti-
human IgE monoclonal antibody HE-2 ascitic fluid diluted 
1:3000 [3]. After further washing, the strips were incubated 
again at room temperature for 1 hour with rabbit anti-mouse 
immunoglobulin conjugated to horseradish peroxidase (RAM-
HRP, DAKO) and diluted 1:5000. Finally, the strips were 
washed and the IgE-binding proteins were detected using 
enhanced chemoluminescence (Amersham Biosciences) 
following the manufacturer’s instructions.
The Figure shows the immunoblot results. The patient’s 
serum IgE recognized proteins of diverse molecular weights 
in the yellow pitahaya extract. The most intense bands were 
high-molecular-weight (HMW) bands ranging from 75 kDa 
to 100 kDa. 
Allergy to pitahaya is uncommon and this is the first case 
reported of allergy to yellow pitahaya. Our search of the 
literature revealed only 2 cases of pitahaya allergy, and in 
both cases the allergy was to the red variety. Furthermore, the 
immunology workup showed that the serum of both patients 
recognized a band of approximately 1 kDa, which could 
correspond to the LTP of pitahaya [4,5]. In our patient, only 
HMW bands were recognized. The most intense bands ranged 
from 75 kDa to 100 kDa, a finding that coincides with reports 
by García-Menaya et al [6] in the case of allergy to prickly 
pear, which also belongs to the Cactaceae family. 
In summary, we have presented the first case of allergy to 
yellow pitahaya, in which an IgE-mediated hypersensitivity 
mechanism was demonstrated by means of an oral challenge 
test and an immunology workup. An HMW protein (75-100 kDa) 
is likely to have triggered the reaction. More complex methods 
for identifying proteins are necessary to accurately determine 
the group of food allergens to which this protein belongs.
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The demand for specialist consultations is growing in the 
public health service in Navarra, Spain, resulting in longer 
waiting lists, increased health costs, and undesirable delays 
in the evaluation of certain patients. Most consultations 
received at the allergy department in our hospital come from 
primary care. Improving communication between general 
practitioners (GPs) and specialists could resolve numerous 
queries and avoid unnecessary referrals, thereby reducing costs 
and improving quality of care. However, making decisions 
based simply on “corridor talk” has negative and even legal 
implications [1]. The lack of relevant patient information and 
the absence of a written document recording the exchange of 
information are the most important obstacles.
The growth of online technologies is a fact in Navarra´s 
public health system, where all physicians now have access 
to electronic medical records (EMRs). In 2005, the Primary 
Care-Allergy Coordination Committee at our hospital designed 
an online medical consultation model (OMC) to facilitate the 
rapid exchange of information between GPs and allergists 
and provide access to additional EMR data to guide clinical 
decisions. It had the added advantage of leaving a written 
record of each communication. The slogan used to promote 
the use of the protocol was “Not sure whether to refer? Make 
an OMC”. We present the results of our experience with the 
OMC for the period spanning 2005 to 2011.
The system was designed drawing on the experience 
of countries with geographically very disperse populations 
that have created online patient-professional platforms that 
have produced encouraging results in pilot studies [1,2]. We 
developed an e-consultation form with the following fields: 
identification of patient and GP, personal medical history, 
and reason for consultation. The GP filled in and sent this 
form to an allergist who within 48 hours issued a report that 
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was recorded in the EMR and automatically sent to the GP. 
The report included advice on how to manage the patient and 
specified whether or not the patient should be referred to the 
allergy department. A third option was to recommend that the 
patient be referred at a later stage, i.e. if the allergist’s advice 
did not produce the desired outcome. The committee promoted 
the protocol through internal communication channels and 
explanatory visits to primary care centres.
We analyzed the source of (adults vs children) and 
reasons for OMCs (respiratory symptoms, cutaneous 
symptoms, adverse drugs reactions [ADRs], adverse 
food reactions [AFRs], doubts about immunotherapy, 
miscellaneous, and administrative issues). We also recorded 
the allergists’ recommendation (refer, do not refer, act and 
then refer if necessary).
We received 667 OMCs: 481 (72.1%) for adults and 
186 (27.9%) for children. The reasons for the OMCs for the 
total sample and for adults/children separately were ADRs 
(185 [27%], 163/22), respiratory symptoms (145 [22%], 
97/48), cutaneous symptoms (97 [14%], 76/21), AFRs 
(92 [14%], 36/56), immunotherapy doubts (52 [7.8%], 
48/4), miscellaneous (49 [7%], 29/20), and administration 
issues (47 [7%], 32/15). In 60% of cases (64% in adults, 
50.5% in children), the OMCs were resolved online, and in 
an additional 13% (14%, 13%), referral was recommended 
only if the allergist’s advice was ineffective. AFRs and 
Figure. Advice on referral for whole sample (A), adults (B), and children (C) according to the reason for consultation. ADR indicates adverse drug 
reaction; RS, respiratory symptoms; CS, cutaneous symptoms; AFR, adverse food reaction; IT, doubts regarding immunotherapy; Miscel, miscellaneous; 
AI, administrative issues.
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respiratory symptoms were the most common reasons for 
referral (Figure).
Demand for specialist consultations is increasing 
exponentially in the Spanish public health system, leading 
to long wait lists. While specialist consultation (and early 
intervention) will clearly benefit some patients, for others, it 
will have little value. We designed our OMC system in the 
hope that it would reduce unnecessary referrals by facilitating 
and leaving a legally documented account of communication 
between GPs and allergists. Because the system needed to be 
dynamic, we established a deadline of 48 hours.
Almost 75% of the OMCs were resolved online, 
avoiding unnecessary face-to-face encounters that would 
have been of little additional value for the patients 
and resulting in considerable health cost savings. The 
proportion of cases resolved was higher in adults than 
in children. The system proved very useful for resolving 
problems related to immunotherapy, cutaneous symptoms, 
and diseases of doubtful allergic etiology. Most (88%) 
of the consultations in these areas were resolved online. 
ADRs were the main reason for consultation for adults and 
nearly 70% (17% of all OMCs) were resolved online. In 
children, referral was recommended for 2 of every 3 ADRs, 
possibly indicating a different pattern among children 
(fewer adverse effects, more recent reactions…). A similar 
proportion of OMCs related to respiratory symptoms were 
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resolved in the 2 groups. Referral was recommended for a 
third of patients, a third of cases were resolved online, and 
in the remaining third advice was given about additional 
tests or treatment.
Direct referral was recommended for over half of the 
queries about AFRs. These were the most common reason for 
OMCs in children but only the forth most common in adults, 
possibly explaining the higher proportion of direct referrals 
among children (36% vs 22% in adults).
Although the number of OMCs received was modest (667), 
the project was welcomed by GPs since it allowed them to 
quickly resolve doubts regarding given cases. Moreover, it 
served a deterrent for poorly supported requests for specialist 
visits.
The literature describes online platforms designed to 
replace face-to-face primary care consultations [1,2]. These 
projects have been criticized because of confidentiality 
concerns and the fact that physicians frequently have to 
work with incomplete and unstructured information. These 
shortcomings have led to recommendations to regulate such 
platforms [3]. The goal of the OMC system at our hospital was 
not to reduce the number of face-to-face specialist visits but 
rather to improve the quality of care by avoiding unnecessary 
visits that could be solved with better communication between 
GPs and specialists. We designed a system that guaranteed 
confidentiality and allowed physicians to work with accurate 
information. 
The preliminary results of our OMC project applied to 
allergy consultations are promising. We think that this project, 
to our knowledge the first of its kind, is applicable to the 
Spanish public health system since it helps to reduce workload 
and improves the efficiency and dynamics of specialist 
consultations. It also allows a prioritization of cases that will 
benefit from early intervention and a reduction in costs derived 
from unnecessary visits.
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Nijmegen breakage syndrome (NBS) is a rare DNA repair 
disorder characterized by microcephaly, normal intelligence, 
primary immunodeficiency, and predisposition to cancer [1,2]. 
It has been reported in different populations but the vast 
majority of patients are of Slavic origin (Central-East Europe) 
and are homozygous for a founder mutation of the NBS1 gene: 
the 5-base-pair deletion 657del.A.
Lung infections are a common presentation of primary 
immunodeficiency. Gastrointestinal disorders such as 
diarrhea, malabsorptive enteropathy, and inflammatory bowel 
disease may also be the first manifestation of underlying 
immunodeficiency [3,4]. Patients with NBS usually present 
with lung infections or lymphoid malignancy. Gastrointestinal 
manifestations other than infections are not readily recognized 
in NBS [1,2].
 We present a 20-year-old man with NBS who 
developed malabsorptive enteropathy. Four years earlier, 
he had been investigated for recurrent lung infections. 
Hypogammaglobulinemia was detected and substitution 
therapy with intravenous immunoglobulin (IVIG) was 
initiated. The diagnosis of NBS was confirmed by mutation 
analysis of the NBS1 gene, which revealed the typical deletion. 
Laboratory investigations at the time of diagnosis yielded 
the following results: hemoglobin, 133 g/L; red blood cell 
count, 4.5 x 1012/L; white blood cell count, 14.7 x 109/L with 
90% neutrophils and 10% lymphocytes (absolute lymphocyte 
count, 910/mm3); serum proteins, 55 g/L; and albumins, 31 g/L. 
Immunoglobulin (Ig) levels were decreased: IgA, 0.12g/l, IgM, 
0.18 g/L, and IgG, 0.8 g/L. Phenotypic analysis of peripheral 
blood lymphocytes revealed a low CD4+lymphocyte count, 
at 136 cells/mm3. The result of qualitative HIV DNA by PCR 
test was negative. 
At the age of 19 years, the patient had started to complain 
of abdominal discomfort associated with loose, frequent or 
fatty stools. 
Microcephaly and characteristic facial features such as 
large ears, a prominent midface, and a receding mandible 
(Figure A) were observed, together with several cafe-au-
lait spots and clinodactyly. The patient’s height (175 cm) 
was normal. His body weight (44 kg) and body mass index 
(14.35 kg/m²) were below the fifth percentile for his age and 
his head circumference (49 cm) was below the third percentile. 
During follow-up, several courses of oral metronidazole 
were given for presumed giardiasis, without improvement. 
Repeated stool cultures for pathogenic microbes and smears 
for Giardia species were negative. Microscopic examination 
of duodenal aspirate and specimens of duodenal biopsy 
were negative for trophozoites. Histological examination 
of the duodenal biopsy specimen showed subtotal villous 
atrophy (Figure B). Serum endomysial and reticulin 
antibodies, as well as IgA and IgG antibodies against tissue 
transglutaminase, were negative. Serologic HLA typing 
showed an absence of celiac disease–associated HLA 
alleles (HLA-A1, B8, cw7, DQ2, DQ8). The colonoscopic 
examination was normal. 
A gluten-free diet with supplementation with liposoluble 
vitamins was attempted but the patient’s enteropathy worsened. 
Also, in spite of regular IVIG substitution, the serum IgG 
trough level decreased from 5 g/L to less than 1.5 g/L. The 
patient developed symptoms of osteomalacia with excruciating 
bone pain, restricting his physical activity. The gluten-free diet 
was stopped 4 months later. 
Laboratory investigations performed at that time revealed 
total serum Ca++, 1.38 mmol/L (ionized Ca 0.98++ mmol/L); 
low phosphorus levels, 0.34 mmol/L; and low serum albumins, 
21 g/L. Thyroid function tests were normal and alkaline 
phosphatase levels were increased (1995 IU/L; normal 
300 IU/L). The serum parathormone level was elevated 
(300 pg/mL; normal range, 18-65 pg/mL). 
Oral budesonide at a dose of 6 mg/d together with 
a high dose of synthetic vitamin D analog and calcium 
supplementation was started. Over the next 6 months the 
symptoms of chronic diarrhea subsided and the daily dose 
of budesonide was reduced to 3 mg and discontinued after 
1 year of treatment. He gained weight (up to 50 kg) and 
was able to sit and walk again. His mineral bone density 
and serum biochemical analyses normalized. At the same 
time, stable trough IgG levels above 5 g/L were achieved 
through standard, monthly IVIG therapy. Duodenal biopsy 
was repeated and histological examination revealed normal 
morphology of the small intestine. At the time of writing, 18 
months after completion of treatment with budesonide, our 
patient is in good general health and is free of celiac-like 
sprue symptoms.
In certain forms of primary immunodeficiency, 
gastrointestinal disorders such as acute or chronic diarrhea, 
sprue-like enteropathy, inflammatory bowel disease, or 
neoplasms may be a cause of significant morbidity. 
The true incidence of gastrointestinal disease in NBS is 
unknown. In the first report of the International Nijmegen 
Breakage Syndrome Study Group, gastrointestinal infections 
and chronic diarrhea were reported in only 3 of 55 patients [1]. 
However, in a preliminary report from the NBS Registry, the 
frequency of GI infections was 15% [2]. By contrast, 20% to 
60% of patients with common invariable immunodeficiency 
(CVID) develop chronic diarrhea, which is frequently 
associated with giardiasis [5]. At first, we treated our patient 
for presumed giardiasis but the symptoms of his enteropathy 
worsened. 
In our patient the diagnosis of celiac-like sprue was 
confirmed by the histologic finding of flat villous lesions. It 
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has been proposed that villous flattening observed in CVID is 
an immune-mediated, inflammatory phenomenon resembling 
celiac disease but without the presence of gut autoantibodies 
and without response to a gluten-free diet. Investigations in our 
patient showed a lack of antibodies to gliadin, endomysium, 
and tissue transglutaminase, as well as an absence of celiac-
associated HLA genes. These findings are similar to those 
reported for celiac-like sprue in CVID [4]. Altogether, these 
findings indicate that chronic, noninfectious enteropathy is due 
to a dysregulated T-cell system. Luzi et al [6] reported that the 
presence of villous atrophy in CVID was significantly associated 
with decreased CD4+ lymphocyte counts (<400/mm3), similarly 
to in our patient. 
Systemic steroids have been found to be useful for the 
treatment of inflammatory bowel disease–like disease or 
celiac-like sprue in CVID [4,5,7]. In patients with CVID, a 
gluten-free diet led to additional weight loss in celiac-like 
sprue, and remission was achieved only with the use of 
steroids [7]. Steroids are necessary to reduce small bowel 
inflammation and restore normal mucosal architecture.
Oral budesonide, a synthetic steroid with potent topical 
glucocorticoid activity but low systemic bioavailability, has 
been successfully used to treat celiac-like sprue in CVID 
patients who do not respond to systemic steroids [8,9]. We 
have reported on the successful use of oral budesonide for 
celiac-like sprue in NBS. 
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Proton pump inhibitors (PPIs) are widely used for 
the treatment of acid-related gastrointestinal diseases [1]. 
Omeprazole was the first PPI to be developed, followed by 
lansoprazole, pantoprazole, rabeprazole, and esomeprazole [2]. 
Hypersensitivity reactions to omeprazole are rare, although 
several case series have been published [1,3-5].
We report on 11 cases of allergic reactions to omeprazole 
that were diagnosed in our department between 2003 and 
2013. We used skin tests and/or oral challenges to confirm the 
diagnosis. Eleven patients (8 women and 3 men) aged 31 to 64 
years (mean age, 43.09 years) were referred to our department 
with adverse reactions to omeprazole. Onset of symptoms 
was immediate in 5 patients and occurred after 1 hour in the 
other 6 patients. The symptoms reported were anaphylaxis 
(4 patients), urticaria (6 patients), and urticaria accompanied 
by angioedema (1 patient). In 7 patients, other drugs were 
implicated when the patients described the reaction with 
omeprazole. These were ibuprofen in 3 patients; amoxicillin-
clavulanic acid and ibuprofen in 1 patient; amoxicillin and 
ibuprofen in 1 patient; amoxicillin-clavulanic acid in 1 
patient; and amoxicillin and clarithromycin in 1 patient. We 
performed a single-blind oral challenge with ibuprofen and 
skin tests and a single-blind oral challenge with amoxicillin, 
amoxicillin-clavulanic acid, and clarithromicyn. All the results 
were negative and we therefore ruled out these drugs as casual 
agents. All the patients had previously tolerated omeprazole. 
The patients gave their written consent before the skin and 
oral challenge tests.
Skin prick tests were performed with the undiluted 
commercial preparation for omeprazole (Normon SA) and 
esomeprazole (Astra Zeneca SA) at 40 mg/mL, pantoprazole 
(Combino Pharma SL) at 20 mg/mL, lansoprazole (Normon 
SA) at 15 mg/mL, and rabeprazole (Janssen-Cilag SA) at 20 
mg/mL. Intradermal tests were performed with omeprazole 
(0.4 mg/mL and 4 mg/mL), esomeprazole (0.4 mg/mL 
and 4 mg/mL), pantoprazole (0.2 mg/mL and 2 mg/mL), 
lansoprazole (0.15 mg/mL and 1.5 mg/mL), and rabeprazole 
(0.2 mg/mL and 2 mg/mL). Histamine and buffered saline 
were used as positive and negative controls, respectively. The 
Table. Results of the Allergy Study
Case Omeprazole Rabeprazole Lansoprazole Pantoprazole Esomeprazole OCT
1 ND ND ND ND ND OMEP +
2 ND ND ND ND ND OMEP +
3 ND ND ND ND ND OMEP +
4 SPT - SPT - SPT - SPT - SPT - OMEP + 
 IDT - IDT - IDT - IDT - IDT - 
5 SPT + SPT - SPT - SPT - SPT - ND 
 IDT ND IDT + IDT + IDT + IDT +
6 SPT - SPT - SPT - SPT - SPT - OMEP + 
 IDT - IDT - IDT - IDT - IDT - PANTOP -
7 SPT - SPT - SPT - SPT - SPT - OMEP ND 
 IDT - IDT - IDT - IDT - IDT - LANSOP - 
      PANTOP - 
      RABEP -
8 SPT - SPT - SPT - SPT - SPT - ND 
 IDT+ IDT+ DT- IDT+ IDT-
9 SPT + SPT - SPT - SPT + SPT + ND 
 IDT+ IDT+ IDT+ IDT+ IDT+
10 SPT + SPT + SPT + SPT + SPT + ND 
 IDT+ IDT+ IDT+ IDT ND IDT ND
11 SPT - SPT - SPT - SPT + SPT + ND 
 IDT+ IDT+ IDT+ IDT+ IDT+ 
Abbreviations: IDT, intradermal test; Lansop, lansoprazole; ND, not done; OCT, oral challenge test; Omep, omeprazole; Pantop, 
pantoprazole; Rabep, rabeprazole; SPT, skin prick test.
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results of skin tests carried out in 10 control patients, (5 atopic 
and 5 nonatopic) were negative.
In the case of patients who did not undergo skin tests 
or who had negative results in these tests, we carried out 
a single-blind oral challenge with omeprazole and other 
PPIs to investigate cross-reactivity. Dose were increased at 
1-hour intervals, as follows: omeprazole (5, 10, and 20 mg), 
lansoprazole (3.75, 7.5, and 15 mg), rabeprazole (5, 10, and 
20 mg), pantoprazole (10, 20, and 40 mg) and esomeprazole 
(5, 10, and 20 mg). In nonimmediate reactions, the therapeutic 
dose was subsequently taken at home every 24 hours for 7 
days. The results of the allergy study are shown in the Table.
Skin tests were carried out in 8 of the 11 patients. Patients 
1, 2, and 3 did not undergo skin tests, because we only started 
to perform skin tests with PPIs in 2009 and these patients 
had already been studied. The result of the oral challenge 
with omeprazole in these patients (1, 2, and 3) was positive. 
Patients 1 and 3 experienced generalized urticaria several 
hours after the challenge (cumulative dose, 35 mg) and patient 
2 experienced anaphylaxis (intense itching with hives on the 
chest and back, dyspnea, and wheezing) 50 minutes after 
the second dose (cumulative dose, 15 mg). The symptoms 
of all 3 patients resolved with systemic antihistamines and 
corticosteroids. Since data on sensitization to omeprazole and 
cross-reactivity between PPIs were lacking, we advised the 
patients to avoid this group of drugs.
The skin tests with PPIs were positive for omeprazole in 5 
patients (5, 8, 9, 10, and 11). In addition, 3 patients (5, 9, and 
10) had a positive skin prick test to omeprazole. All patients 
with positive skin test results for omeprazole also had positive 
skin tests results for the other PPIs tested. Patients 5, 9, 10, 
and 11 tested positively to the PPIs studied, and patient 8 had 
a positive skin test to rabeprazole and pantoprazole. However, 
because of cross-reactivity between PPIs, we recommended 
that the patients avoided this group of drugs.
Patients 4, 6, and 7 had negative skin test results for all 
the PPIs tested. The diagnosis was based on a positive oral 
challenge with omeprazole in patients 4 and 6, with a delayed 
reaction in both. After the oral challenge test, the therapeutic 
dose was subsequently taken at home every 24 hours for 
7 days. Six days after the oral challenge (cumulative dose, 
155 mg), patient 4 experienced generalized urticaria. Patient 
6 experienced urticaria on her legs 4 days after the oral 
challenge test (cumulative dose, 105 mg). Patient 7 refused 
to undergo the oral challenge test with omeprazole. Owing 
to the negative skin test results and in order to investigate 
possible cross-reactivity between PPIs, we performed a single-
blind oral challenge with the other PPIs. Patient 6 tolerated 
pantoprazole, and no other PPIs were tested. Patient 7 tolerated 
lansoprazole, pantoprazole, and rabeprazole. As patient 4 
refused an oral challenge with the other PPIs, we recommended 
avoidance of all the drugs in this group.
PPIs have revolutionized the treatment of acid-related 
disorders [3]. Omeprazole is widely used, and the incidence of 
allergic reactions to this agent has increased in recent years [4]. 
Diagnosis of hypersensitivity to PPIs is difficult, since PPIs 
are often used in combination with other drugs [1]. Seven 
of our 11 patients were taking drugs other than omeprazole. 
Although skin tests have been used to investigate reactions 
to PPIs, this is not standard practice. Bonadonna et al [1] 
analyzed 53 patients with immediate reactions to PPIs and 
compared the diagnostic performance of skin tests with that 
of oral challenge tests. Abdul Razzak et al [4] described a 
series of 9 patients sensitized to omeprazole, of whom 5 had 
a positive intradermal test result with omeprazole. In a report 
of 9 patients with IgE-mediated allergy to omeprazole, Lobera 
et al [3] reported that 8 of the patients had positive skin test 
results. In our series, we obtained positive skin test results in 
5 out 8 patients.
Bonadonna et al [1] suggested the usefulness of skin tests 
in patients with immediate hypersensitivity reactions to PPIs, 
but our findings do not necessarily support this. For example, 
patients 4 and 6 had negative omeprazole skin tests, yet reacted 
when challenged with omeprazole. This indicates that the 
negative predictive value of skin testing is poor. Furthermore, 
patients 8 to 11 had positive skin tests, but they were not 
challenged with any PPIs. Therefore, the positive predictive 
value of skin testing is uncertain. In our series, skin tests were 
negative in patients with a delayed reaction.
Numerous studies have investigated cross-reactivity 
between PPIs [1]. Omeprazole and pantoprazole have a 
methoxy and a difluoromethoxy chain in their benzimidazole 
ring respectively, whereas lansoprazole and rabeprazole do not. 
Pérez Pimiento et al [2] described a case of anaphylaxis due to 
lansoprazole with cross-reactivity to rabeprazole. The authors 
considered that the analogous chemical structure could have 
been responsible for the cross-reactivity. Bonadonna et al [1] 
observed that patients with hypersensitivity to pantoprazole 
had positive skin test results to omeprazole and, more rarely, 
esomeprazole. Patients monosensitized to lansoprazole 
and rabeprazole had negative test results for omeprazole, 
pantoprazole, and esomeprazole. In our series, we did not 
observe comparable results. 
We have reported on a series of 11 patients sensitized 
to omeprazole. Diagnosis was based on skin tests and oral 
challenges. More studies with a larger number of patients are 
needed to investigate the usefulness of skin tests in patients 
with immediate hypersensitivity reactions to PPIs.
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Numerous studies have shown that air pollution worsens 
asthma and increases emergency room visits due to asthma 
exacerbations [1]. However, pollution is also deposited 
on the ground and can directly affect seed, root, and plant 
development and bacteria associated with the plant. In 
addition, the environmental stress generated by pollutants can 
make pollens more allergenic [2-4]. 
In recent years, endotoxins from Gram-negative bacteria 
have been associated with airway inflammation and 
exacerbations in asthmatic patients; nevertheless, in early 
childhood, endotoxins may drive immune development 
towards the nonallergic type 1 helper T cell (TH1) profile [5,6]. 
Gram-negative bacteria and endotoxins have been detected 
on the surface of allergenic pollen, although the role of these 
entities in pollinosis remains unclear [7,8].  
Against this background, we conducted a study in 2 
Spanish cities sharing the same type of pollen and situated 
about 40 km apart. One was Puertollano, which has intense 
industrial activity and high levels of pollution, and the other 
was Ciudad Real, which has a service-based economy and 
low levels of pollution. The main objective of our study was 
to determine whether air pollution increases the allergenicity 
of Lolium perenne (ryegrass) pollen collected in Puertollano 
compared with that collected in Ciudad Real and a commercial 
sample (Allergon). We selected ryegrass because it is the most 
frequent cause of seasonal respiratory allergy worldwide. Our 
secondary objective was to analyze the presence of gram-
negative bacteria (Enterobacteriaceae) in pollen samples from 
the 2 cities. 
During the peak pollination period (May), L perenne plants 
were collected from areas of Puertollano and Ciudad Real 200 
to 300 m away from road traffic to reduce the impact of diesel 
exhaust particles. Mature pollen was obtained by suction.  
The grass pollen species from Puertollano and Ciudad 
Real and the commercial pollen (Allergon) were extracted in 
50% wt/vol phosphate-buffered saline (PBS) at 4-8°C. The 
extracts were stirred for 2 hours (1000 rpm) and the solution 
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was centrifuged at 10 000g for 30 minutes. The resulting 
supernatant was passed through glass filters and dialyzed 
(cutoff 3.5 kDa) against distilled water for 12 hours at 4°C. 
The extract was then vacuum-filtered through 0.22-µm filters 
(Millipore) and frozen at –20°C for lyophilization. The protein 
concentration of the final extract was determined by the 
Bradford assay as previously described. 
Proteins from the extract were analyzed using sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), according to Laemmli. The binding of IgE antibody to 
allergens was analyzed using Western blot with a pool of sera 
from grass-sensitized patients and antihuman IgE peroxidase 
conjugate (SouthernBiotech). Chemiluminescence detection 
reagents (Western Lightning Chemiluminescence Reagent Plus 
Perkin Elmer Inc.) were added according to the manufacturer’s 
instructions. 
Enzyme-linked immunosorbent assay (ELISA)–inhibition 
test of the different grass extracts was performed by 
preincubating the pool of sera with extracts of the samples 
(Allergon, Puertollano, and Ciudad Real) at concentrations 
ranging from 0.040 µg/mL to 30 µg/mL. After washing 
with PBS 0.05% Tween 20, plates were neutralized with 
1% bovine serum albumin (1 hour at room temperature), 
washed, and incubated with free-phase samples (2 hours 
at room temperature). IgE binding was detected using a 
biotinylated human anti-IgE monoclonal antibody (1:1000; 
50 µL/well; Operon) followed by incubation with a mouse 
anti-IgE antibody marked with streptavidin peroxidase. After 
a final wash, a substrate solution was added and the color was 
allowed to develop. The enzyme reaction was stopped and the 
absorbance values were measured at 450 nm.
We also performed a study of Enterobacteriaceae according 
to the method described by Spiewak et al [7]. Briefly, 10-fold 
serial dilutions of the pollen sample extracts were prepared, 
and 0.1 mL of each dilution was spread on duplicate sets of 
eosin methylene blue agar plates (Difco). The plates were 
incubated for 24 hours at 37°C. The colonies were counted, 
and the results were reported as colony forming units (cfu) 
per gram of pollen. 
Immunoblotting showed that L perenne pollen from 
Puertollano had greater recognition than the pollen from 
Allergon and Ciudad Real (Figure). 
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Figure. SDS PAGE and immunoblotting: lane 1, Allergon; lane 2, pollen 
from Puertollano; lane 3, pollen from Ciudad Real. SDS PAGE indicates 
sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Likewise, the ELISA-inhibition test showed a greater 
inhibition capacity in L perenne from Puertollano.
Analysis of Enterobacteriaceae revealed bacterial counts of 
up to 97 600 cfu/g in the sample from Puertollano compared 
to 25 600 cfu/g in the sample from Ciudad Real. 
We found that L perenne pollen from the polluted city 
showed higher allergenic potency. These results are consistent 
with those obtained by other authors. Cortegano et al [2] 
found that Cupressus arizonica pollen from polluted areas 
expressed a large amount of Cup a 3, an allergen belonging to 
the pathogenesis-related protein family. Aina et al [3] reported 
that Poa annua pollen exposed to cadmium-contaminated 
soils produced high levels of allergenic proteins. The authors 
also detected stress-related allergenic proteins such as a PR3 
class 1 chitinase-like protein. Eckl-Dorna et al [4] detected an 
increase in the protein and allergen content of Secale cereale 
pollen exposed to high levels of ozone.
We found significantly higher Enterobacteriaceae counts 
in the pollen from Puertollano, suggesting that this pollen 
had an increased capacity for endotoxin release. Endotoxins 
amplify the immune response and induce airway inflammation, 
worsening the clinical course of asthma and increasing 
bronchial hyperresponsiveness [6-8]. 
Our study of the clinical course of pollen-allergic 
patients with asthma in Puertollano and Ciudad Real showed 
that asthmatics from Puertollano had increased symptoms 
and medication use associated with the concentration of 
pollutants, in particular with ozone exceedances [9,10]. Our 
current findings could help to explain the poorer clinical 
course of asthmatic patients from Puertollano, although the 
proinflammatory effect of pollution itself on the airways must 
not be ignored. 
In conclusion, patients living in areas with high levels 
of pollution are at risk of the direct effect of pollution on the 
airways. Moreover, L perenne pollen from polluted areas can 
induce a more intense response in grass-allergic patients than 
pollen from nonpolluted areas. 
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b-Lactam antibiotics are widely used as first-line 
treatment of infectious diseases and as prophylactic treatment 
before surgery. All antibiotics belonging to this family are 
characterized by a common ring, known as the b-lactam 
ring. Penicillins have a thiazole ring, and cephalosporins a 
dihydrothiazine ring [1]. b-Lactams also possess at least 1 
side chain, which is responsible for the differences within 
each group. Cephalosporins have 2 side chains. Some 
cephalosporins share identical side chains with penicillin, as 
is the case with amoxicillin, which shares a side chain with 
cefadroxil, ampicillin, and cephalexin [1,2]. 
Given their widespread use in the population, b-lactams 
are the most frequently involved drug in hypersensitivity 
reactions to antibiotics. Not all aspects of the cross-reactivity 
pattern between penicillins and cephalosporins have been 
clarified. Cephalosporins and penicillins share the b-lactam 
ring, which is considered the main antigenic determinant. 
A study conducted in 41 adults diagnosed with immediate 
hypersensitivity reaction to penicillin found no adverse effects 
after administration of cephalosporins [2]. 
A study conducted in a group of 1170 children with 
suspected immediate allergic reactions to cephalosporins, 
penicillins, or both showed that 58.3% of cases had positive 
skin or challenge test results, with cross-reactivity between 
cephalosporins and penicillin ranging between 0.3% and 
23.9% [3]. The overall incidence of adverse reactions 
from cephalosporins has been shown to range from 1% to 
10% [4].
All first-generation cephalosporins have the potential for cross-
reactivity, probably because their structural features are similar to 
those of penicillin, whereas most second- and third-generation 
cephalosporins are highly unlikely to be associated with cross-
reactivity because of differences in their chemical structure [5]. 
Much of the information available on cross-reactivity 
between cephalosporins and penicillins comes from studies of 
immediate hypersensitivity reactions and adult studies. Few 
studies have evaluated cross-reactivity between these 2 groups 
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Table. Clinical Data of Patients
Case Gender Age, y Drug Cephalosporin Case Gender Age, y Drug Cephalosporin 
    Administered     Administered
1 Male 12 Ax Cefixime 16 Female 1.6 Ax-Clav Cefuroxime
2 Male 3.9 Ax-Clav Cefuroxime 17 Male 4.1 Ax Cefuroxime
3 Female 6.3 Ax Cefuroxime 18 Male 3.1 Ax-Clav Cefuroxime
4 Male 5.6 Ax Cefaclor 19 Female 1.4 Ax Cefuroxime
5 Male 5.6 Ax-Clav Cefuroxime/Cefixime 20 Female 4 Ax Cefuroxime
6 Female 4.9 Ax Cefuroxime 21 Male 2.25 Ax-Clav Cefuroxime
7 Male 3.41 Ax-Clav Cefuroxime 22 Male 1.8 Ax-Clav Cefuroxime
8 Male 7 Ax Cefuroxime 23 Female 3.5 Ax-Clav Cefuroxime
9 Male 8.9 Ax Cefuroxime 24 Female 1.25 Ax Cefuroxime
10 Male 7 Ax-Clav Cefuroxime 25 Male 1 Ax Cefixime
11 Male 2.6 Ax Cefuroxime 26 Male 2.5 Ax Cefuroxime
12 Male 8.3 Ax Cefuroxime 27 Male 1 Ax Cefuroxime
13 Female 4.1 Ax Cefuroxime/Cefaclor 28 Female 7.6 Ax Cefuroxime
14 Male 3.7 Ax Cefuroxime/Cefaclor 29 Male 4 Ax-Clav Cefuroxime/Cefaclor
15 Male 2.7 Ax-Clav Cefuroxime 30 Male 5.5 Ax-Clav Cefuroxime
Abbreviations: Ax, amoxicillin; Ax-Clav, amoxicillin-clavulanate.
in delayed reactions, and, to our knowledge, no studies have 
been published on this problem in children.
The aim of our study was to evaluate tolerance to 
cephalosporins in pediatric patients diagnosed with 
nonimmediate allergy to penicillins.
We studied 30 patients diagnosed with delayed 
hypersensitivity to penicillins in the Pediatric Allergy Department 
of the Gregorio Marañon Maternity and Pediatric Hospital.
All patients underwent skin prick and intradermal tests 
with known concentrations of the culprit drug [6]. The reagents 
used included amoxicillin (GSK) 20 mg/mL, benzylpenicillin 
(Normon), penicilloyl-polylysine (5 x 10-5 mmol/L, Diater) 
and minor determinant mixture (2 x 10-2 mmol/L, Diater). 
We also performed prick tests with 1 or 2 cephalosporins as 
alternative drugs (cefuroxime 2 mg/mL, cefaclor 2 mg/mL, 
and cefixime 2 mg/mL) [7]. Histamine 10 mg/mL and sodium 
chloride (0.9%) were used as positive and negative controls, 
respectively. Immediate readings were taken after 15 minutes 
and late readings at 24 hours. A prick or intradermal test result 
was considered positive if the largest diameter of the wheal 
was ≥3 mm or ≥5 mm, respectively, as recommended by the 
guidelines of the European Academy of Allergy and Clinical 
Immunology [8]. The same experienced nurses performed the 
tests. In patients with negative skin tests against penicillin, 
allergy was demonstrated by oral challenge test.
Once nonimmediate allergy to penicillins was confirmed, we 
performed a controlled challenge test with oral cephalosporin 
(cefuroxime, cefaclor, and cefixime) according to the clinical 
situation of the individual patient. All patients received one-
quarter of the total dose followed by the remainder of the dose 
and were kept under observation for 1 hour after the last dose. 
They followed 1 week of home treatment with therapeutic 
doses of the drug adjusted to body weight.
Out of 30 patients, 21 were men and 9 women. The 
median age at the time of the reaction was 3.9 years (1-12) 
years. Amoxicillin was involved in 18 patients (60%) and 
amoxicillin-clavulanate in 12 patients (40%). Our findings 
agree with those reported in the literature, where amoxicillin 
alone or in combination with clavulanic acid is the drug most 
frequently involved in drug-induced reactions in children [9]. 
Maculopapular rash was recorded in 29 patients (96%), 
and osteoarticular involvement with skin involvement was 
recorded in 6 patients (20%).
We performed 34 challenges in 30 patients with 
cephalosporins (Table). All patients tolerated the drugs.
Our study confirms good tolerance to cephalosporins 
in patients diagnosed with nonimmediate hypersensivity 
reaction to penicillins. If the results of a graded challenge 
test are negative, the patients do not need to avoid the tested 
cephalosporin.
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We present the case of a 17-year-old woman monitored 
at our Allergology Service for allergic rhinitis and moderate 
persistent bronchial asthma. She was sensitized to house dust 
mite, grass pollen, and cat and rabbit epithelia. She kept a 
rabbit at home and had sporadic contact with cats. She had 
received specific immunotherapy against house dust mites for 
5 years and had taken oral ebastine and inhaled salmeterol/
fluticasone, which led to partial control of her bronchial 
symptoms. She currently lives without pets. 
In January 2011, she experienced generalized 
maculopapular rash, itching, shortness of breath, coughing, 
wheezing, and pharyngeal tightness 30 minutes after ingestion 
of rabbit paella (rice, red and green pepper, onion, garlic, 
paprika, and rabbit meat) and went to the hospital emergency 
department where she was diagnosed with generalized urticaria 
and severe bronchospasm. She denied contact with animals 
and reported that she tolerated all the suspect foods except 
paprika and rabbit, which she has not eaten since. She also 
tolerates all kinds of mammal and bird meats, processed meats, 
eggs, and dairy products. She has never been exposed to hare 
and has never eaten hare meat. The patient did not report 
associated cofactors (eg, physical exercise, nonsteroidal anti-
inflammatory drugs, and alcohol). Prick testing was performed 
with the following groups of allergens: aeroallergens, namely, 
dust mites, pollens, musts, epithelia (horse, goat, pig, rabbit, 
guinea pig, cat, hamster, sheep, dog, and cow), and latex; 
standard foods (eggs, milk, and grains), mix of meats (pork, 
rabbit, chicken, and lamb), nuts, vegetables, fish, seafood, 
fruits, Anisakis simplex, mustard, legumes, and soy; individual 
meats (horse, pork, rabbit, chicken, and veal). Spices were 
also tested (prick), as were paprika and red and green pepper 
(prick-prick). Prick-prick testing was performed with raw and 
cooked meat (rabbit, pork, beef, and chicken). The histamine 
control was positive (5 x 4 mm). Forced basal spirometry and 
exhaled nitric oxide were determined. IgE was determined 
using ImmunoCAP Specific IgE (Pharmacia) CAP system 
and IgE-immunoblotting (ALK-Abelló) with extracts of rabbit 
epithelium, rabbit meat, dog epithelium, and pork.
In the case of aeroallergens, the results were positive 
for grass pollen, grains, Phleum pratense, Phragmites 
communis, Olea europaea, Dermatophagoides pteronyssinus, 
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Dermatophagoides farinae, Lepidoglyphus destructor, cat 
epithelia (4 × 4 mm), and rabbit epithelia (6 × 5 mm). All 
results for standard foods, spices and peppers, and raw and 
cooked meats were negative. The only positive result in the 
prick test with individual meats was for rabbit meat (10 × 7 
mm). Prick-prick testing with rabbit meat was positive (raw, 
9 × 7 mm; cooked, 4 × 4 mm). Forced basal spirometry was 
normal, and exhaled nitric oxide was 54 ppb.
The results of testing with the ImmunoCAP revealed total 
IgE of 676.9 kUA/L. The results for specific IgE (IU/mL) were 
as follows: D pterynossinus, >100; D farinae, >100; Phleum 
pratense, 1.1; cat epithelia, 1.1; dog epithelium, 0.5; rabbit 
epithelium, 4.19; rabbit meat, 0.51; rabbit serum proteins, 0.90; 
rabbit urine proteins, 0.83. The results of testing for hamster 
epithelium, horse dander and epithelium, bovine serum 
albumin (BSA), pork, beef, chicken, paprika, and mustard were 
negative. Immunoblotting with the patient’s serum sample 
revealed recognition of rabbit epithelium proteins (60, 35, and 
75 kDa), whereas only a single band (60 kDa) was observed 
with the rabbit meat sample.
suggesting that albumins may be responsible for both 
respiratory and environmental allergies. BSA has been reported 
to be the main allergen in children, whereas g-globulins and 
myoglobins may be equally or more relevant in adults [6].
The rabbit belongs to the Leporidae family (rabbits/hares). 
The literature contains cases of severe reactions after exposure 
to rabbit epithelium but few cases of allergy due to ingestion 
of rabbit meat. In 2006, Fernández Rivas and Benito Sastre [7] 
reported the cases of 2 patients with rhinoconjunctivitis and 
asthma caused by exposure to inhaled rabbit epithelium 
who subsequently developed anaphylaxis after ingestion of 
rabbit meat. In the first case, the reaction was associated with 
physical exercise, and in the second, the patient presented 
oropharyngeal pruritus, rhinoconjunctivitis, and asthma. 
Albumin was the culprit allergen (>60 kDa). In 2007, Osorio 
Galindo [8] reported the case of a patient with occupational 
asthma due to exposure to rabbit meat vapors who experienced 
respiratory symptoms after ingestion, suggesting that the 
patient experienced primary sensitization by inhalation to cat 
epithelium, subsequent sensitization by inhalation to rabbit 
derivatives, and evolution to sensitization to rabbit meat by 
ingestion. In contrast with cases published to date, the patient 
in the present case experienced an immediate reaction after 
eating rabbit meat (symptoms of generalized cutaneous and 
acute respiratory anaphylaxis), with no associated cofactors 
or history or symptoms of oral allergy syndrome due to rabbit 
meat (this type of meat was common in the patient’s diet). In 
our case, the 60-kDa protein detected could correspond to 
albumin. The patient was only sensitized to rabbit, with IgE 
specific for BSA. The results for other meats were negative, 
and the patient only presented symptoms after ingestion of 
rabbit meat and good tolerance to other mammalian meats. 
In conclusion, we present the case of a patient diagnosed 
with initial sensitization to inhaled rabbit products (epithelium, 
urine, and serum) at age 11 years. She became sensitized to 
rabbit meat, and, at age 16, reported symptoms of anaphylaxis 
secondary to ingestion (severe bronchospasm). The 60-kDa 
band identified could correspond to albumin, a panallergen 
responsible for cross-reactivity between rabbit epithelium 
and rabbit meat. 
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The patient was sensitized to house dust mites and grass 
and olive pollen.
The only positive results in prick testing, prick-prick 
testing, and CAP were detected with rabbit meat.
The prevalence of allergy to meat is fairly low, and reports 
on this allergy are scarce. In adults, prevalence has been 
reported to be 8.2% [1]. 
Several allergens are found in the flesh of mammals, 
including serum albumins, bovine serum g-globulin, actin, 
and tropomyosin, although few seem to be clinically relevant. 
Various clinical allergic reactions have been described after 
ingestion, inhalation, or contact with meat products, and 
symptoms vary in severity (oral allergy syndrome, urticaria, 
dermatitis, asthma, and anaphylaxis), thus indicating an IgE-
mediated mechanism [2]. The literature contains descriptions 
of patients allergic to cow’s milk and sensitized to BSA 
who experience symptoms if the meat is undercooked [3-4]. 
There have also been reports of cross-reactivity between cat 
epithelium and pork and/or lamb and of allergy to hamster 
epithelium with symptoms after ingesting horse meat [5], 
Figure. IgE immunodetection. Lane 1, rabbit epithelium; lane 2, rabbit 
meat; lane 3, dog epithelium; lane 4, pork; –, negative controls incubated 
with buffers instead of patient serum; +, incubation with patient serum.
1- 1+ 2- 2+ 3- 3+ 4-
137
Practitioner's Corner
J Investig Allergol Clin Immunol 2014; Vol. 24(2): 122-141© 2014 Esmon Publicidad
4. Martínez-Alonso JC, Moneo I, Gómez M, Alday E. 
Hipersensibilidad a sangre de cordero y reacción cruzada con 
otros mamíferos. Rev Esp Alergol Inmunol Clín. 1998;13:359-
61.
5. Cisteró-Bahima A, Enrique E, San Miguel-Moncín MM, Alonso 
R, Bartra J, Fernández Parra B, Lombardero M, Barber D. Meat 
allergy and cross-reactivity with hamster epithelium. Allergy. 
2003;58:161-2.
6. Fiocchi A, Restani P, Riva E, Bruni P, Santini I, Galeone M, Galli 
CL, Velonà T. SPT to different meats and serum albumins in 
atopic, beef SPT-positive children. Allergy. 1995;50:63.
7.  Fernández Rivas M, Benito Sastre C. Alergia a conejo. In: 
Sociedad Madrid-Castilla La Mancha de Alergología e 
Inmunología Clínica. Sesiones interhospitalarias 2004-2005. 
Madrid: Ed. Luzán 5, S.A; 2006. p.27-34.
8. Osorio Galindo A. Asma en la cocina. In: Sociedad Madrid-
Castilla La Mancha de Alergología e Inmunología Clínica. 
Sesiones interhospitalarias 2005-2006. Madrid: Ed. Luzán 
5,S.A; 2007. p.209-16.
  Manuscript received December 30, 2012; accepted for 
publication June 4, 2013. 
Catalina Gómez Galán
C/ Joan Soler, 1-3
Manresa, Spain
E-mail: cgomezga@althaia.cat 
Tolerance of Triflusal in Patients With Immediate 
Cutaneous Hypersensitivity to Nonsteroidal Anti-
inflammatory Drugs
M Sánchez,1 T Lobera,1 MD Del Pozo,1 R Escudero,2 
I Gonzalez,1 A Blasco1
1Allergy Section, Hospital San Pedro, Logroño, La Rioja, Spain 
2Allergy Section, Hospital Fundación Calahorra, Calahorra, La 
Rioja, Spain
Key words: Urticaria. Angioedema. NSAIDs. Triflusal. 
Palabras clave: Urticaria. Angioedema. AINEs. Triflusal.
When used as an antiplatelet agent, acetylsalicylic 
acid (ASA) plays an important role in reducing ischemic 
complications arising from coronary artery disease [1,2,3]. 
ASA is a nonselective inhibitor of cyclo-oxygenase that 
prevents synthesis of thromboxane A2, an inducer of platelet 
aggregation [1,4]. Dual antiplatelet therapy can prevent 
cardiovascular thromboembolic events in risk populations, 
in which the most commonly used agents are clopidogrel and 
ASA [1,5].
Patients with hypersensitivity reactions to ASA who require 
antiplatelet therapy can use clopidogrel as an alternative [5]. 
However, if dual antiplatelet therapy is necessary, tolerance 
to ASA should be induced [6]. In some cases, complete 
desensitization is not possible or the underlying disease makes 
the procedure risky. 
Triflusal is structurally related to the salicylates [5]. 
Its efficacy in preventing cardiovascular events after acute 
myocardial infarction is similar to that of ASA, although 
it has a more favorable safety profile and better digestive 
tolerance [1,5]. In addition, triflusal is well tolerated by patients 
with asthma induced by nonsteroidal anti-inflammatory 
drugs (NSAIDs). Based on the classification of Kowalski et 
al [8], we present prospective data on patients with cutaneous 
hypersensitivity reactions to ASA to confirm tolerance to 
triflusal. 
This prospective study was conducted between 2009 
and 2012 in 18 patients (9 men) aged 23 to 80 years (mean, 
45 years) with immediate cutaneous reactions (7 urticaria, 6 
angioedema, and 5 urticaria and angioedema) after intake of 
NSAIDs confirmed by oral challenge test with ASA. None of 
the patients had a history of chronic urticaria or respiratory 
disease. The most frequently involved drugs were ibuprofen 
and aspirin (11 and 9 patients, respectively). 
The results of skin tests (prick and intradermal) with 
several NSAIDs (ASA, ibuprofen, dypirone, diclofenac, 
indomethacin, and ketorolac) performed to rule out selective 
IgE-mediated reactions were negative in all the patients.
In order to confirm hypersensitivity to ASA, all 18 patients 
underwent a controlled, single-blind, oral challenge test with 
aspirin. Increasing doses of ASA were administered orally at 
intervals of 60 minutes (50, 125, and 250 mg on day 1; and 
500 mg on day 2). In some patients, dosing started at 25 mg. 
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All the patients experienced urticaria, angioedema, or both, 
that is, the same manifestations as in the initial case (8 patients) 
after the highest dose. Seventeen patients were classified as 
having cross-intolerance because of reactions with more than 1 
NSAID. In the remaining patient, who reported reactions only 
with ASA, cross-intolerance was not ruled out. The clinical 
characteristics of the patients and the results of the challenge 
tests are shown in the Table.
Table. Clinical Data of Patients
Age Gender Symptoms Drug Not  Triggering 
   Tolerated Dose 
    of ASA
63 Male A ASA, ibuprofen,  25 mg 
   dypironel, diclofenac  
32 Female A ASA, indomethacin  125 mg
65 Male U ASA, ibuprofen,  250 mg 
   dypirone  
27 Female A Dypirone, ASA  500 mg
22 Female A Ibuprofen, paracetamol  125 mg
37 Female U/A Dypirone, ibuprofen  500 mg
39 Male U Ibuprofen  500 mg
46 Male U Ibuprofen, ASA  500 mg
72 Male U/A ASA 100 mg
46 Male U/A ASA, ibuprofen 250 mg
45 Female U/A ASA, dexketoprofen 125 mg
54 Female U Ibuprofen, ketorolac,  500 mg 
   dypirone 
28 Female A Ibuprofen 125 mg
36 Male A ASA, Ibuprofen 500 mg
38 Male U Ibuprofen 125 mg
33 Female U Ibuprofen 500 mg
52 Male U/A Ibuprofen 500 mg
80 Female A Ibuprofen, ASA 250 mg
Abbreviations: A, angioedema; ASA, acetylsalicylic acid; U, 
urticaria; U/A, urticaria-angioedema.
All of the patients underwent a controlled, oral, single-
blind challenge test with triflusal at increasing doses (75 mg, 
150 mg, and 300 mg administered at 60-minute intervals) 
until a cumulative dose of 525 mg was reached. On day 2, the 
patients received 300 and 600 mg of triflusal. 
All 18 patients tolerated a cumulative dose of triflusal of 
525 mg, and 6 patients tolerated a cumulative dose of 900 mg. 
No adverse events were reported.
Patients with intolerance to ASA who need antiplatelet 
therapy can use clopidogrel as the first alternative drug. If dual 
antiplatelet therapy is necessary, tolerance should be induced 
with ASA [6]. Adverse reactions are common during induction. 
These are usually mild, although they can be dangerous, 
particularly in patients who have recently experienced a 
cardiovascular event. Treatment with triflusal has a similar 
efficacy to that of ASA in the prevention of cardiovascular 
events (death, nonfatal myocardial infarction, and nonfatal 
cerebrovascular events) with a significantly lower incidence of 
nonfatal cerebrovascular events and cerebral hemorrhage [1,4]. 
The recommended dosage in adults is 600-900 mg/d (600 mg 
qd, or 300 mg bid or tid) [9]. Our study shows that triflusal 
is well tolerated by patients with immediate cutaneous 
hypersensitivity to ASA. Similar results were obtained in a 
previous study in patients with NSAID-induced asthma [7]. 
The fact that triflusal is a weaker cyclo-oxygenase inhibitor 
than ASA may explain this difference [7]. 
In our opinion, triflusal is a safe alternative drug in patients 
with immediate cutaneous hypersensitivity to NSAIDs if dual 
antiplatelet therapy is necessary.
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Hydrolyzed wheat protein (HWP) is used in many foods 
and in personal hygiene products, including skin cosmetics, 
shampoo, hair conditioner, and facial soap. Allergic contact 
dermatitis due to HWP has been reported by several authors [1-5]. 
Here, we describe an extremely rare case of bilateral allergic 
conjunctivitis caused by HWP in facial soap. 
A 28-year-old woman with no previous history of atopy 
or allergic contact dermatitis developed severe bilateral 
allergic conjunctivitis 1 hour after washing her face with a 
new soap (Cha no Shizuku, Yuuka Co Ltd). She attended our 
hospital 2 days after the onset of allergic conjunctivitis and 
stated that soap bubbles had entered her eyes while she was 
washing her face. She had no history of skin disorders or 
allergic conjunctivitis. We checked the ingredients of her facial 
soap and confirmed that it contained HWP. On examination, 
the patient’s vision was better than 20/20 in both eyes, and 
she had bilateral severe conjunctival hyperemia and edema 
(Figure). The cornea was clear. The facial skin, upper and 
lower eyelids, anterior chamber, iris, and lens were normal, 
as were funduscopy findings. The skin prick test was positive 
after 30 minutes for facial soap and wheat (1:20 wt/vol; Torii 
Pharmaceutical Co, Ltd); the result of the skin prick test with 
the saline control was negative. Total IgE in tear fluid was 
grade 2 (elevation of total IgE) according to the Allerwatch test 
(Hitachi Chemical Co., Ltd and Wakamoto Pharmaceutical Co, 
Ltd) [6], and wheat-specific IgE in tear fluid was grade 4 (the 
highest specific IgE level) according to the IMM-FAST Check 
J2 test (Mitsubishi Kagaku Iatron Inc) [7-8]. The results of 
skin prick tests for other major allergens, such as pollen, dust 
mite, and animal dander, were all negative, and tear levels of 
specific IgE were not elevated. The patient was diagnosed with 
allergic conjunctivitis induced by HWP in soap. She stopped 
using the facial soap and was treated with eye drops (0.1% 
betamethasone sodium phosphate [Shionogi] and 0.025% 
levocabastine hydrochloride [Santen Pharmaceutical]), which 
were administered 4 times daily to both eyes. Her symptoms 
subsided within a few days, and the allergic conjunctivitis 
resolved completely in 1 week.
In this patient, acute allergic conjunctivitis was presumably 
caused by direct contact with facial soap containing HWP. 
Acute allergic conjunctivitis induced by facial washes is 
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extremely rare and has never been described in the literature 
to our knowledge.
The early symptoms of allergy to HWP-containing soap are 
facial dermatitis, contact dermatitis, and allergic rhinitis [1-5]. 
Long-term use of HWP-containing soap may also induce 
wheat-dependent exercise-induced anaphylaxis [9-10]. In 
the case we report, the patient developed bilateral allergic 
conjunctivitis after washing her face with HWP-containing 
soap because soap bubbles entered her eyes. However, she 
did not experience facial dermatitis or rhinitis because she 
rinsed her face thoroughly with water and dried it with a clean 
towel. This suggests that HWP-containing soap residue in the 
conjunctival sac can penetrate the conjunctiva, a thin mucous 
membrane with abundant blood vessels, more easily than facial 
skin. In addition, soap contains surfactants that can damage the 
conjunctival barrier, thus facilitating penetration of HWP into 
the conjunctival epithelium. If HWP-containing soap enters 
the eyes of a patient with HWP hypersensitivity, he/she should 
immediately rinse the eyes thoroughly.
We report a case of hypersensitivity reaction to HWP-
containing soap. On May 20, 2011, the company voluntarily 
began to recall about 46 million cakes of HWP-containing 
soap. However, many other cosmetics and soaps still contain 
HWP. Thus, we believe that this case emphasizes the need 
for caution when HWP-containing cosmetics are used by 
persons with HWP allergy or wheat allergy. Treatment with 
topical antiallergic agents and corticosteroids can achieve 
rapid resolution of allergic conjunctivitis caused by HWP-
containing soap.
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